Institutional re-evolution of mitral valve procedures
Matteo Ponzoni1
Alessandro Fiocco1
Raphael Caraffa1
Matteo Nadali1
Lorenzo Longinotti1
Nicola Pradegan1
Olimpia Bifulco1
Laura Besola1
Luca Nai Fovino1
Giuseppe Tarantini2
Andrea Colli3
Gino Gerosa1
1.Cardiac Surgery Unit,Department of Cardiac,Thoracic,Vascular Sciences and Public Health,University of Padua,Italy2.Interventional Cardiology Unit,Department of Cardiac,Thoracic,Vascular Sciences and Public Health,University of Padua,Italy3.Cardiac Surgery Unit,Department of Surgical,Medical and Molecular Pathology and Critical Care Medicine,University of Pisa,Italy
摘要：The introduction of transcatheter aortic valve replacement changed our approach for those patients with a high-to-prohibitive risk profile, and, more recently, for those with an intermediate- to-low risk profile.[1] Similarly, patients with mitral valve regurgitation (MVR) can now benefit from various transcatheter technologies, whose indications and recommendations are the subject of intense clinical investigation.
机标关键词：institutionalmitralproceduresre-evolutionvalve
论文发表日期：2022-07-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：4( 551-554 )